ENTITY

Medexus Pharmaceuticals (MEDXF US)

17
Analysis
Health Care • Canada
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on therapeutic areas such as rheumatology, auto-immune disease, specialty oncology, and pediatrics. Medexus Pharmaceuticals serves customers North America and Canada.
more
bullish•Fortive
•09 Jun 2025 09:20

Weekly Update (MEDXF, IDT, FTV)

Fortive (FTV) will spin off 100% of Ralliant on June 28, 2025. Ralliant will trade under the ticker RAL. When issued trading will begin on June 25th.

Logo
406 Views
Share
bullish•ABB Ltd
•21 Apr 2025 10:37

Weekly Update (ABB, MEDXF, LION)

April 17, 2025, ABB Ltd (ABB) announced its intention to spin off its entire robotics division. The robotics unit, recognized as the world’s second...

Logo
524 Views
Share
•03 Mar 2025 09:26

Best Idea of 2025: Medexus Pharmaceuticals

Medexus (MDP.TO / MEDXF) is my best idea for 2025. The stock trades at a distressed valuation despite the current launch of a new drug that could...

Logo
380 Views
Share
x